This announcement is made following an agreement between Joe Thomas, managing member of Inpulse Phoenix and VitalCare, for 100% of Inpulse Phoenix’s interest in the Scottsdale, Arizona diabetes treatment center.
The clinic is currently administering intracellular activation therapy treatments using the FDA approved and the US patented technology and proprietary clinical protocols to patients suffering from Type 1, Type 2 and secondary complications of Type 2 diabetes.
Jimmy McDougald, CEO and chairman of VitalCare, said: “This is the first of many acquisitions VitalCare has lined up as part of our acquisition strategy. The Phoenix center is an ideal model with experienced staff and great location as a VitalCare Diabetes Treatment Centers affiliate.”